Atherogenic Index

The Atherogenic Index, also called AI, is a lipid-related biomarker reported as a ratio. It summarizes a relationship involving lipid measurements in a compact form, helping describe an aspect of lipid status rather than representing a single lipid value.

Atherogenic Index is measured from a serum sample collected through a blood test. Fasting is required, so the laboratory or clinician arranging the test should provide preparation instructions in advance. Following those instructions helps ensure the sample is collected under the conditions intended for this measurement.

The result is reported as a ratio rather than as a concentration. It is interpreted using the reference and optimal ranges shown with the test, and lower values are considered better. The result can be viewed alongside the related cholesterol markers displayed on the page, since they provide context for understanding the ratio.

When arranging testing, confirm that the laboratory can measure Atherogenic Index from serum and ask how long fasting should last. A clinician can help interpret the result alongside other cholesterol findings and the reason the test was requested.

This result is a ratio measured in serum, and lower values are considered better. The reference range is the broader interval used to identify results that fall within the expected range, while the optimal range is narrower. A result can therefore be within the reference range without being within the tighter optimal range.

Interpret the number against the reference and optimal ranges printed with the report rather than in isolation. Laboratories may use different ranges or units, so the report’s own range is the relevant comparison. Fasting is required for this measurement; a result collected without the required preparation may not be directly comparable.

A single value is not a diagnosis and does not, by itself, establish the presence or absence of a medical condition. Results outside the report’s reference range should be discussed with a clinician, who can interpret them in context.

Because a lower Atherogenic Index is considered better, interventions that directly measured this marker are most relevant to interpreting changes. Omega-3, Curcumin, and Panax Ginseng each moved the index downward in their respective trials, while Garlic left it unchanged overall. These findings describe direct measurement of the Atherogenic Index rather than an inference from related cardiovascular markers.

The direct-measurement findings were assessed over roughly 12 to 16 weeks for the longer studies. Panax Ginseng is an exception: its reduction was observed after a single dose, at 240 min. Differences in intervention, study timing, and participant characteristics mean that these results should not be treated as interchangeable or as a general treatment recommendation. For a medical condition or decisions about changing treatment, interpretation with a clinician is appropriate.